Suchergebnisse - "Vasudevan, Abhinav"

PubPharm (96)

61

A difficult pill to swallow : drug-induced oesophagitis

enthalten in: Lancet (London, England) | 2019

von Apostolov, R. | Tan, N. | Vasudevan, A.

62

Systematic Review : Cost-effective Strategies of Optimizing Anti-tumor Necrosis and Immunomodulators in Inflammatory Bowel Disease

enthalten in: Inflammatory bowel diseases | 2019

von Vasudevan, A. | Gibson, P. | Van Langenberg, D.

63

Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn's Disease

enthalten in: Digestive diseases and sciences | 2019

von Vasudevan, A. | Raghunath, A. | Anthony, S. | +4

64

A comparison of long-term healthcare utilization and costs in patients with acute severe ulcerative colitis receiving infliximab versus early colectomy

enthalten in: Therapeutic advances in chronic disease | 2019

von Vasudevan, A. | Arachchi, A. | Scanlon, C. | +2

65

Management of Patients With Erythropoietic Protoporphyria–Related Progressive Liver Disease

enthalten in: Liver Transplantation | 2019

von Ardalan, Z. | Chandran, S. | Vasudevan, A. | +9

66

Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn’s Disease

enthalten in: Digestive diseases and sciences | 2018

von Vasudevan, A. | Raghunath, A. | Anthony, S. | +4

67

Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn’s Disease

enthalten in: Digestive diseases and sciences | 2018

von Vasudevan, A. | Raghunath, A. | Anthony, S. | +4

68

Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn’s Disease

enthalten in: Digestive diseases and sciences | 2018

von Vasudevan, A. | Raghunath, A. | Anthony, S. | +4

69

Long-term safety and efficacy of tenofovir disoproxil fumarate substitution for hepatitis B immunoglobulin following liver transplantation

enthalten in: JGH open : an open access journal of gastroenterology and hepatology | 2018

von Vasudevan, A. | Ardalan, Z. | Ahmed, N. | +5

70

Letter : overcoming secondary loss of response to infliximab-it is not the drug, it is how you use it!

enthalten in: Alimentary pharmacology & therapeutics | 2018

von van Langenberg, D. | Vasudevan, A.

CommentOn: Aliment Pharmacol Ther. 2018 Feb;47(3):346-355. - PMID 29226370